Bioinformatics Market Size, Share, Trends | Global Forecast 2028

Bioinformatics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Bioinformatics Platforms, Knowledge Management Tools, and Bio Informative Services), Application (Genomics, Proteomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, and Others), and Sector (Medical Biotechnology, Animal Biotechnology, Agricultural Biotechnology, Academics, Environmental Biotechnology, Forensic Biotechnology, and Others)

  • Report Code : TIPRE00003993
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 206
Buy Now

The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is estimated to grow at a CAGR of 15.7% from 2022 to 2028.

Market Insights and Analyst View:

Bioinformatics is the application of information technology to manage biological data that helps in decoding plant genomes. The bioinformatics stores, analyses and interprets the big data generated by life-science experiments, or collected in a clinical context. This multidisciplinary field is driven by experts from a variety of backgrounds including biologists, computer scientists, mathematicians, statisticians and physicists. Bioinformatics allows researchers to perform experiments on a timeline that matters in a person’s lifetime. For example, during the coronavirus pandemic, researchers were able to sequence the virus’s genome, identify what was likely to be causing the virus to enter cells, and develop a vaccine based on the discovered genome within a matter of months. Additional bioinformatic approaches are being used to identify and treat other diseases like diabetes and cancer. The growth of the bioinformatics market is attributed to the increasing funding and investments in bioinformatics, and increased number of genomic research activities with corresponding adoption of bioinformatics are expected to propel the bioinformatics market growth during the forecast period.

Growth Drivers and Challenges:

In the field of genetics and genomics, the bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and more generally in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals, such as to reduce global health inequalities by providing developing countries with efficient, cost-effective, and robust means of preventing, diagnosing, and treating major diseases that burden their populations. Currently, cancer treatment is also set to gain from genomic information to predict how an individual responds to drugs and inform prescription of the appropriate drug or dosage.

The initiatives to generate and collect human genomic data is evolving rapidly and is highly diverse, with private and public initiatives across multiple countries. Since 1990, the cost of sequencing a whole genome dropped from US$ 2.7 million to as low as US$ 300, opening new opportunities to build repositories of genomic data. By the start of 2020, there were 187 genomic initiatives globally of which 50% originated in the U.S. and 19% in Europe. Thirty-eight million genomes had been analyzed using techniques ranging from genotyping to whole genome sequencing, and this number is expected to grow to 52 million by 2025. Therefore, the increasing number of genomics activities along with rising adoption of bioinformatics is driving the market.

One of the challenges is that bioinformatics is a collection of different fields – structural biology, genomics, chemical biology, etc – and they’re all moving very quickly. New techniques are coming online almost daily, there are lots of new data types, so keeping up with the deluge of new things is very difficult.  

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Bioinformatics Market: Strategic Insights

Market Size Value inUS$ 12,609.39 Million in 2021
Market Size Value byUS$ 34,749.78 Million by 2028
Growth rateCAGR of 15.7% from 2022 to 2028
Forecast Period2022-2028
Base Year2022
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The “Global Bioinformatics Market” is segmented based on product, application, sector, and geography. Based on the product, the bioinformatics market is segmented into bioinformatics platforms, knowledge management tools, and bioinformative services. Based on application, the bioinformatics market is segmented into genomics, proteomics, chemoinformatics & drug design, transcriptomics, metabolomics, and others. Based on sector, the bioinformatics market is divided into medical biotechnology, animal biotechnology, agricultural biotechnology, academics, environmental biotechnology, forensic biotechnology, and others. The bioinformatica market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Segmental Analysis:

The bioinformatics market is segmented based on product into bioinformatics platforms, knowledge management tools, and bioinformative services. The bioinformatics platforms segment held the largest market share in 2021; however, knowledge management tools are anticipated to register the highest CAGR during the forecast period. The major driving factor for the growth of this segment is the increasing number of more advanced and automated product developments and growing availability in the lower-middle income countries. Developments in the bioinformatics platforms have helped the bioinformatics market to grow significantly. For instance, in August 2022, Predicine launched its CE-marked PredicineCARE for genomic profiling in blood and urine in Europe. The cell-free DNA (cfDNA) assay is a targeted next-generation sequencing (NGS) assay for detecting single nucleotide variants, insertions and deletions, DNA rearrangements, and copy number variations in patients diagnosed with cancer. The assay has been used in clinical trials, patient testing, and the development of companion diagnostics.

Bioinformatics Market, by Product – 2022 and 2028

Bioinformatics Market, by Product – 2022 and 2028
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Based on application, the bioinformatics market is segmented into genomics, proteomics, chemoinformatics & drug design, transcriptomics, metabolomics, and others. The genomics segment held the largest market share in 2021; however, chemoinformatics and drug design are anticipated to register the highest CAGR in the market during the forecast period. Due to innovative product developments and rising research in the sector segments, the segment's growth will be augmented in the forthcoming years. Genetics is currently one of the most dynamic sciences in medicine, and genetic data plays a vital role in all areas of medicine. Within a few years, technological advancements are converted from research to clinical testing, and there has been a significant increase in Direct to Consumer (DTC) genetic testing. The consumer receives results online, usually without a human interface or consultation, and later seeks professional advice.

Based on sector, the bioinformatics market is divided into medical biotechnology, animal biotechnology, agricultural biotechnology, academics, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. The major driving factors for the growth of the sector segment are rising advancements and the growing demand for bioinformatics tools.

Regional Analysis:

Based on geography, the bioinformatics market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North bioinformatics market has been analysed based on three major countries — the US, Canada, and Mexico. The US is estimated to hold the largest bioinformatics market share during the forecast period. The US government initiated various research programs to boost the genomic research, including the ‘All of Us Research Program’ led by NIH, which provided US$ 28.6 million in funding to develop three genome centers across the US. This research program will accelerate the precision medicine discoveries through Bioinformatics services in different institutions in the US. The supportive environment in the US accelerates the growth of the development and commercialization of pharmaceutical and biopharmaceutical products. The market players in the country received various patents for their innovations. Thus, the growing bioinformatics services and product launches for various genetic diseases and cancer studies in the pharmaceutical & biopharmaceutical industries will boost the Bioinformatics market growth. For instance, in June 2022, California’s biotechnology research startup LatchBio has introduced an end-to-end bioinformatics platform for handling big biotech data to accelerate scientific discovery. It allows biologists to organize data and run processes, bioinformaticians to upload new workflows, and computational biologists to do downstream analysis.

Asia Pacific accounted for the fastest-growing region in the global bioinformatics market and was projected to grow at a faster pace over the forecast period. The market in this region is largely held by countries such as China and Japan. The factors contributing to the growth of the bioinformatics market in these countries are advancements in the field of genomics and proteomics, generating massive volume of data, which is to be interpreted and managed.

Bioinformatics Market Trend:

Bioinformatics and AI are playing critical roles in changing and advancing the healthcare industry. In the context of bioinformatics, AI can be used to promote clinical research and analysis that can result in the design of new drugs and vaccines, the diagnosis of diseases, and even the prediction of pandemics. One example of how AI can be used in conjunction with bioinformatics is wearable tech. Consumers are already familiar with many types of wearable techs, such as fitness trackers and watches, and make personal use of the data they collect. The wearable tech provides real-time data over a period of time and can help track trends and identify signs of potentially fatal health issues, such as heart disease, much quicker and more accurately than spot tests conducted in laboratories. Also, genome sequencing plays a pivotal role in medical diagnostics. Machine learning empowered DNA sequencing techniques such as next-generation sequencing have made it possible for researchers to sequence human genomes within a day compared to the traditional sanger sequencing technology, which took over a decade to sequence a human genome. The integration of AI and machine learning in bioinformatics is showing the current trend in bioinformatics market.

Covid-19 Impact:

Bioinformatics market witnessed a positive impact due to increased demand for COVID-19 detection kits during the pandemic. At the biological level, SARS-CoV-2 and COVID-19 research involves high-throughput technologies such as Next-Generation Sequencing for detecting the genome of SARS-CoV-2, databases storing SARS-CoV-2 genomes and variants, bioinformatics software tools and databases for analyzing and storing host-virus interactions. At the medical level, the search for therapeutic strategies, the identification of COVID-19 biomarkers, the discovery of therapeutic targets for drugs, and the bioinformatics approaches for drug repurposing, i.e., the use of already available drugs for the COVID-19 disease, were the main research themes, which further escalated the market growth. Moreover, there has been an increase in the use of synthetic gene-based technologies for studying SAR-CoV-2 virulence and facilitating vaccine development.

The recent two decades' invention and advances in nucleic acid amplification technologies, automated DNA sequencing, and bioinformatics tools revolutionized the characterization and classification of all infectious disease agents. The rising incorporation of bioinformatics methodologies and technology into many areas of the worldwide response to the COVID-19 pandemic is yet another crucial and visible evidence of the essential bioinformatics role in modern science and medicine.

Competitive Landscape and Key Companies:

Some of the prominent players operating in the global bioinformatics market include Agilent Technologies, Inc, Biomax Informatics Ag, Bruker Corporation, Dassault Systems, Eurofins Scientific, Geneva Bioinformatics, Illumina, PerkinElmer, Qiagen, ThermoFisher Scientific, Inc. among others. These companies focus on new technologies, advancement in the existing products and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. For instance, in March 2020, Genesis Healthcare Co., Japan's leading genetic testing and research company, launched GenesisGaia's new genomic-data-marketplace tool for R &D in Japan to empower industry researchers by increasing their productivity in crucial applications such as accelerating drug discovery, clinical development, and precision medicine, as well as strengthening the development of personalized consumer products and services.

In January 2021, Illumina, Inc. has transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). The new and integrated bioinformatics solution provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Application, and Sector

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

Which sector held the largest share in the bioinformatics market?

The medical biotechnology segment dominated the global bioinformatics market and held the largest market share of 29.18% in 2021.

Which are the top companies that hold the market share in Bioinformatics market?

Thermo Fisher Scientific and Agilent Technologies, Inc. are the top two companies that hold huge market shares in the bioinformatics market.

Which region is expected to witness significant demand for bioinformatics market in the coming years?

Global bioinformatics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North America region is the held the largest market for the bioinformatics market during the forecast period. The large share of North America is attributed to factors such as the presence of decreased cost of sequencing, leading bioinformatics providers, government support for genomic research, increased awareness of bioinformatics services, and increased number of genomic research activities in the region are driving the growth of the bioinformatics market in North America. Also, it has a favorable funding scenario for research activities.

What is the COVID 19 impact on the bioinformatics market in the coming years?

The bioinformatics research during the COVID-19 pandemic has given an impulse to the development and adaption of various informatics techniques, including computational methods for tracing and tracking infected people, artificial intelligence methods and robotics applications to support remote patients assistance, collaborative data infrastructures for COVID-19 research and sentiment analysis methods for monitoring the impact of lockdown measures. The introduction of genomics and bioinformatics have contributed immensely to understand infectious disease from disease pathogenesis, mechanisms and the spread of antimicrobial resistance to host immune responses.

Who are the key players in the bioinformatics market?

The Bioinformatics market majorly consists of the players such as Agilent Technologies, Inc, Biomax Informatics Ag, Bruker Corporation, Dassault Systems, Eurofins Scientific, Geneva Bioinformatics, Illumina, Perkinelmer, Qiagen, Thermofisher Scientific, Inc. among others.

What is bioinformatics?

Bioinformatics, as associated with genetics and genomics, is a scientific subdiscipline that involves using computer technology to collect, store, analyze and disseminate biological data and information, such as DNA and amino acid sequences or observations about those sequences. Bioinformatics is essential for the management of data in modern biology and medicine. Scientists and clinicians use databases that organize and guide biological information to increase the understanding of health and disease and, in certain cases, as part of medical care.

Which application held the largest share in the bioinformatics market?

The genomics segment dominated the global bioinformatics market and accounted for the largest market share of 28.33% in 2021.

Which product led the bioinformatics market?

The bioinformatics platforms segment held the largest market share of 48.47% in 2021 in the global bioinformatics market.

What are the driving factors for the bioinformatics market across the globe?

Key factors that are driving the growth of this market increasing funding and investments in bioinformatics and increased number of genomic research activities with the corresponding adoption of bioinformatics are expected to boost the market growth for bioinformatics over the years.

What is the market CAGR value of bioinformatics market during forecast period?

The CAGR value of the bioinformatics market during the forecasted period of 2022-2028 is 15.7%.

The List of Companies - Bioinformatics Market

  1. Dassault Systèmes             
  2. Bruker Corporation            
  3. Agilent Technologies, Inc.                
  4. Eurofins Scientific                
  5. Illumina, Inc.         
  6. PerkinElmer Inc.                  
  7. QIAGEN    
  8. Thermo Fisher Scientific Inc.           
  9. Biomax Informatics AG     
  10. Genebio

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Bioinformatics Market